<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> (GP) IIb/IIIa integrin binds to fibrinogen and thereby mediates platelet aggregation </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we addressed the role of GP IIb for platelet <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and determined the relevance of platelet GP IIb for the processes of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion (I/R) injury </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: GP IIb(-/-) mice were generated and bred with ApoE(-/-) animals to create GP IIb(-/-)ApoE(-/-) mice </plain></SENT>
<SENT sid="3" pm="."><plain>Platelet <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to the mechanically injured or atherosclerotic vessel wall was monitored by in vivo video fluorescence microscopy </plain></SENT>
<SENT sid="4" pm="."><plain>In the presence of GP IIb, vascular injury and early <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> induced platelet <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in the carotid artery (CA) </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, platelet <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> was significantly reduced in the absence of GP IIb integrin (P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>To address the contribution of platelet GP IIb to atheroprogression, we determined atherosclerotic lesion formation in the CA and aortic arch (AA) of GP IIb(+/+)ApoE(-/-) or GP IIb(-/-)ApoE(-/-) mice </plain></SENT>
<SENT sid="7" pm="."><plain>Interestingly, the absence of GP IIb attenuated lesion formation in CA and AA, indicating that platelets, via GP IIb, contribute substantially to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Next, we assessed the implication of GP IIb for cerebral I/R injury </plain></SENT>
<SENT sid="9" pm="."><plain>We observed that after occlusion of the middle cerebral artery, the cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size was drastically reduced in mice lacking GP IIb compared with <z:mp ids='MP_0002169'>wild-types</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These findings show for the first time in vivo that GP IIb not only mediates platelet aggregation but also triggers platelet <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to exposed extracellular matrices and dysfunctional endothelial cells </plain></SENT>
<SENT sid="11" pm="."><plain>In a process strictly involving GP IIb, platelets, which are among the first blood cells to arrive at the scene of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, contribute essentially to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and cerebral I/R injury </plain></SENT>
</text></document>